(Q44557763)

English

Non-ST-segment elevation acute coronary syndrome in patients with renal dysfunction: benefit of low-molecular-weight heparin alone or with glycoprotein IIb/IIIa inhibitors on outcomes. The Global Registry of Acute Coronary Events

scientific article published on 2 June 2005

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Non-ST-segment elevation acute coronary syndrome in patients with renal dysfunction: benefit of low-molecular-weight heparin alone or with glycoprotein IIb/IIIa inhibitors on outcomes. The Global Registry of Acute Coronary Events (English)

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

acute coronary syndrome

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Frans Van de Werf

4

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Gilles Montalescot

2

object named as

Gilles Montalescot

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Jean-Philippe Collet

1

object named as

Jean-Philippe Collet

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

author name string

Giancarlo Agnelli

3

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Enrique P Gurfinkel

5

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Jose López-Sendón

6

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Christopher V Laufenberg

7

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Martin Klutman

8

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Neelam Gowda

9

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Dietrich Gulba

10

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

GRACE Investigators

11

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

publication date

2 June 2005

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

European Heart Journal

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

26

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

21

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

2285-2293

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

Enoxaparin in unstable angina patients who would have been excluded from randomized pivotal trials

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI337

21 January 2018

Predictors of major bleeding in acute coronary syndromes: the Global Registry of Acute Coronary Events (GRACE).

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI337

21 January 2018

Rationale and design of the GRACE (Global Registry of Acute Coronary Events) Project: a multinational registry of patients hospitalized with acute coronary syndromes

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI337

21 January 2018

Renal function: the Cinderella of cardiovascular risk profile

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI337

21 January 2018

Prediction of creatinine clearance from serum creatinine

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI337

21 January 2018

Predictors of hospital mortality in the global registry of acute coronary events

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI337

21 January 2018

Enoxaparin in unstable angina patients with renal failure

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI337

21 January 2018

Safety and efficacy of unfractionated heparin versus enoxaparin in patients who are obese and patients with severe renal impairment: analysis from the ESSENCE and TIMI 11B studies

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI337

21 January 2018

Effect of renal function on the pharmacokinetics of enoxaparin and consequences on dose adjustment

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI337

21 January 2018

Enoxaparin is superior to unfractionated heparin for preventing clinical events at 1-year follow-up of TIMI 11B and ESSENCE.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI337

21 January 2018

Combining enoxaparin and glycoprotein IIb/IIIa antagonists for the treatment of acute coronary syndromes: final results of the National Investigators Collaborating on Enoxaparin-3 (NICE-3) study

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI337

21 January 2018

Relationship of activated partial thromboplastin time to coronary events and bleeding in patients with acute coronary syndromes who receive heparin

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI337

21 January 2018

Anti-Xa activity relates to survival and efficacy in unselected acute coronary syndrome patients treated with enoxaparin

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI337

21 January 2018

Platelet glycoprotein IIb/IIIa inhibitors in acute coronary syndromes: a meta-analysis of all major randomised clinical trials

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHI337

21 January 2018

Identifiers

10.1093/EURHEARTJ/EHI337

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

4 December 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44557763&oldid=2027741578"